Immunology Program; Memorial Sloan-Kettering Cancer Center; New York, NY USA.
Oncoimmunology. 2012 Mar 1;1(2):162-171. doi: 10.4161/onci.1.2.18481.
TGFβ1 is a regulatory cytokine with a crucial function in the control of T cell tolerance to tumors. Our recent study revealed that T cell-produced TGFβ1 is essential for inhibiting cytotoxic T cell responses to tumors. However, the exact TGFβ1-producing T cell subset required for tumor immune evasion remains unknown. Here we showed that deletion of TGFβ1 from CD8(+) T cells or Foxp3(+) regulatory T (Treg) cells did not protect mice against transplanted tumors. However, absence of TGFβ1 produced by activated CD4(+) T cells and Treg cells inhibited tumor growth, and protected mice from spontaneous prostate cancer. These findings suggest that TGFβ1 produced by activated CD4(+) T cells is a necessary requirement for tumor evasion from immunosurveillance.
TGFβ1 是一种调节细胞因子,在控制 T 细胞对肿瘤的耐受方面具有关键作用。我们最近的研究表明,T 细胞产生的 TGFβ1 对于抑制细胞毒性 T 细胞对肿瘤的反应至关重要。然而,对于肿瘤免疫逃逸所需的确切 TGFβ1 产生 T 细胞亚群仍不清楚。在这里,我们表明,从 CD8(+) T 细胞或 Foxp3(+)调节性 T (Treg)细胞中删除 TGFβ1 并不能保护小鼠免受移植肿瘤的侵害。然而,缺失激活的 CD4(+) T 细胞和 Treg 细胞产生的 TGFβ1 抑制肿瘤生长,并保护小鼠免受自发性前列腺癌的侵害。这些发现表明,激活的 CD4(+) T 细胞产生的 TGFβ1 是肿瘤逃避免疫监视的必要条件。